All Stories

  1. Functional hearing and low frequency hearing preservation after cochlear implant surgery is achievable with FLEX electrode arrays: Real world evidence from the MEHS Registry
  2. Early Results from a Pressureless Middle Ear Diagnostic and Its Relation to Tympanometry Types
  3. Strengths and limitations of a multicentric registry for cochlear implants
  4. single sided deaf childrens' auditory threshold in ABR vs ASSR
  5. Recommendations for audiological and technical testing of cochlear implants (AG-ERA/ADANO)
  6. Guidelines for selecting Target Parameters & Process Recommendations in Functional Testing of CI
  7. Tympanic Electrically Evoked Auditory Late Response to check cochlear implant candidacy
  8. Cochlear implant contact estimation based on pre- versus post-operative imaging
  9. Guidance for pre- and intraoperative eAEP like eABR in cochlear implant candidacy
  10. Reducing artifacts in electrically evoked auditory potentials like eABR and eALR
  11. Revisions after prior stapes surgery
  12. Tympanic Electrically Evoked Auditory Late Response to check cochlear implant candidacy
  13. Hearing impairment in people with Osteogenesis Imperfecta
  14. Perilymphatic fistula and cochlear implantation
  15. Clinical results of a totally implantable Cochlear Implant
  16. Der Einfluss von Cochlea-Implantationen bei älteren Menschen mit und ohne kognitive Beeinträchtigung
  17. First experience with a new 34-mm-long cochlear implant array for very long cochleae
  18. Finding the optimal electrode array before cochlear implantation based on CT or MRI
  19. Auswahl der optimalen Elektrode bei Cochlea-Implantat-Kandidaten anhand von CT- oder MRT-Bildern
  20. Cochlear implantation in the elderly using preoperative screening for mild cognitive impairment
  21. Contribution of hearing loss to quality-of-life impairment in Menière patients
  22. Hörverlust und Lebensqualität bei Patienten mit Morbus Menière
  23. Current Trends and Developments in Cochlear Implantation
  24. A patient with cochlear implant and implanted trigeminal nerve stimulator
  25. A patient with cochlear implant and implanted trigeminal nerve stimulator
  26. An objective promontory stimulation test using electrical auditory brainstem response preoperatively
  27. EABR was performed pre-operatively in local and intra-operatively in general anesthesia.
  28. The indication for stapes revision surgery and possible strategies are shown.
  29. Revisionseingriff nach Stapesplastik
  30. Hearing and voice are influencing each other. Patients with cochlear implants were investigated.
  31. Before cochlear implantation, insecure candidates were tested by EABR in local anesthesia.
  32. Preoperative electrically evoked auditory brainstem and cortical potential during local anesthesia
  33. Diagnosis of Menière’s disease
  34. Sprachverstehen und Hörqualität mit verschiedenen Sprachprozessoren nach CI Versorgung
  35. Speech unterstanding and hearing quality using different CI speech processors
  36. Hearing thesholds by ABR vs ASSR in children with cochlear malformation / nerve hypoplasia
  37. Variations in cochlear anatomy analyzed by a new tablet-based software
  38. Variations in cochlear anatomy of patients who underwent cochlear implantation
  39. Variationen der Anatomie der Cochlea bei Patienten nach Versorgung mit einem Cochleaimplantat
  40. Stapes and Stapes Revision Surgery
  41. ABR vs ASSR for estimating hearing in children with high hearing loss
  42. Recommendations for AEP, OAE and impedance audiometry
  43. ADANO-Empfehlungen für AEP, OAE and Impedanz in der Audiometrie
  44. A preoperative eABR in local anesthesia for insecure CI candidacy
  45. Sprachproduktion und Sprachperzeption bei erwachsenen Cochlea Implantat-Trägern
  46. speech intelligibility vs speech perception in cochlear implant patients
  47. Threshold changes of ABR results in toddlers and children
  48. How well can CI users understand speech in different situations
  49. Consensus on Testing in Single-Sided Deafness Studies
  50. Contents Vol. 21, 2016
  51. Monitoring of Therapeutic Progress by COMES®